| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/02/2013 | WO2013060052A1 Hypoallergenic recombinant immunotoxin, and preparation method and application thereof |
| 05/02/2013 | WO2013060020A1 Novel small peptide capable of inhibiting new vessels and application thereof |
| 05/02/2013 | WO2013059886A1 Pat-lm1 epitopes and methods for using same |
| 05/02/2013 | WO2013059879A1 Compositions and methods for the treatment of fibrosis and fibrotic diseases |
| 05/02/2013 | WO2013059876A1 A method of treating mucus hypersecretion |
| 05/02/2013 | WO2013039374A3 Method for extracting, testing and counting dialysed leukocyte extract from shark spleen in order to obtain an enhanced transfer factor, specifically designed to be used as a treatment against the disease known as vitiligo |
| 05/02/2013 | WO2013036902A4 Submicron particles to decrease transfusion |
| 05/02/2013 | WO2013036867A3 Compositions and methods for cancer and cancer stem cell detection and elimination |
| 05/02/2013 | WO2013036622A3 Antiviral peptides effective against hepatitis c virus |
| 05/02/2013 | WO2013025846A3 Transferrin-tumstatin fusion protein and methods for producing and using the same |
| 05/02/2013 | WO2013023166A3 Hapivirins and diprovirins |
| 05/02/2013 | WO2013014134A3 Polyoma virus jc peptides and proteins in vaccination and diagnostic applications |
| 05/02/2013 | WO2012177892A3 Type i interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis |
| 05/02/2013 | WO2012169735A9 Complex comprising water-soluble fragments of fcεri and composition comprising same for treating allergic diseases mediated by ige |
| 05/02/2013 | WO2012135868A8 Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 05/02/2013 | US20130110132 Conditioned medium obtained from stem cells and its use in therapy |
| 05/02/2013 | US20130109636 Tri-amino releasing fulvate |
| 05/02/2013 | US20130109635 Humanin Decreases Liver Fat and Visceral Fat Accumulation |
| 05/02/2013 | US20130109634 Casein Peptide For Use In The Treatment Of Uterine Infections |
| 05/02/2013 | US20130109633 CB-183,315 Compositions and Related Methods |
| 05/02/2013 | US20130109632 Use of vegfr-2 in the treatment of ophthalmic diseases |
| 05/02/2013 | US20130109631 Agent for growing, restoring and regenerating hair and method of producing a preparation containing the same |
| 05/02/2013 | US20130109629 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer |
| 05/02/2013 | US20130109626 Novel peptide and use thereof |
| 05/02/2013 | US20130109624 Novel neurotrophic factors |
| 05/02/2013 | US20130109623 G-csf and water-soluble polymer conjugate |
| 05/02/2013 | US20130109621 Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors |
| 05/02/2013 | US20130109620 Balaglitazone compositions and methods |
| 05/02/2013 | US20130109618 Rna virus-derived peptides with modified side chains |
| 05/02/2013 | US20130109617 Substituted tetracycline compounds for treatment of bacillus anthracis infections |
| 05/02/2013 | US20130109615 Methods for inhibiting necrosis |
| 05/02/2013 | US20130109614 Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins |
| 05/02/2013 | US20130108716 Jatropha Curcas Processing Method and Products |
| 05/02/2013 | US20130108704 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 05/02/2013 | US20130108700 Methods and compositions for wound treatment |
| 05/02/2013 | US20130108683 Compositions and methods for treating partial and full thickness wounds and injuries |
| 05/02/2013 | US20130108682 Wound care product comprising a cathelicidin polypeptide |
| 05/02/2013 | US20130108671 Hemostatic compositions |
| 05/02/2013 | US20130108670 Compositions and methods for treating full thickness burn injuries |
| 05/02/2013 | US20130108667 Method, apparatus and system for electroporation |
| 05/02/2013 | US20130108649 Modulation of ul24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection |
| 05/02/2013 | US20130108644 Inhibition of AXL Signaling in Anti-Metastatic Therapy |
| 05/02/2013 | US20130108641 Anti-gitr antibodies |
| 05/02/2013 | US20130108630 Amino acyl trna synthetases for modulating inflammation |
| 05/02/2013 | US20130108614 Wound healing peptides and methods of use thereof |
| 05/02/2013 | US20130108613 Amyloid-beta clearance |
| 05/02/2013 | US20130108612 Polynucleotides encoding novel pcsk9 variants |
| 05/02/2013 | US20130108610 Inhibition of Microbial Growth by Aconitase Inhibition |
| 05/02/2013 | US20130108608 tRNA synthetase fragments |
| 05/02/2013 | US20130108607 Methods and Compositions for Treating Oxalate-Related Conditions |
| 05/02/2013 | US20130108605 Method of ameliorating oxidative stress and supplementing the diet |
| 05/02/2013 | US20130108602 Methods and uses of nur77 and nur77 agonists to modulate macrophages and monocytes, and treat inflammation, inflammatory disease and cardiovascular disease |
| 05/02/2013 | US20130108582 Methods of use of cyclopamine analogs |
| 05/02/2013 | US20130108579 Methods of using small compounds to enhance myeloid derived suppressor cell function for treating autoimmune diseases |
| 05/02/2013 | US20130108578 Apo-2 ligand variants and uses thereof |
| 05/02/2013 | CA2853791A1 N-acyldipeptide derivatives and their uses |
| 05/02/2013 | CA2853472A1 Pharmaceutical composition and kit for treating bacterial infections |
| 05/02/2013 | CA2853379A1 Vectors encoding rod-derived cone viability factor |
| 05/02/2013 | CA2853364A1 Nmda receptor modulators and uses thereof |
| 05/02/2013 | CA2853358A1 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof |
| 05/02/2013 | CA2853356A1 Hemostatic compositions |
| 05/02/2013 | CA2853187A1 A method of treating mucus hypersecretion |
| 05/02/2013 | CA2852709A1 Pat-lm1 epitopes and methods for using same |
| 05/02/2013 | CA2852633A1 Topk peptides and vaccines including the same |
| 05/02/2013 | CA2852536A1 Methods and compositions for treating pain |
| 05/02/2013 | CA2852019A1 Method for preparing highly concentrated fibrinogen solution and method for preparing fibrin sealant by using thereof |
| 05/02/2013 | CA2851690A1 Treatment protocol of diabetes type 2 |
| 05/01/2013 | EP2586865A2 Recombinant vector for suppressing proliferation of human papillomavirus cell including adenylate cyclase activating polypeptide 1 (pituitary) gene and pharmaceutical composition for treating human papillomavirus |
| 05/01/2013 | EP2586794A2 Manufacture, Compositions and Uses of Coagulationfactor VIIA Modulator |
| 05/01/2013 | EP2586793A1 Chimeric molecule involving oligomerized FasL extracellular domain |
| 05/01/2013 | EP2586459A1 VEGF antagonist formulations |
| 05/01/2013 | EP2586458A1 Compositions and methods for treating inflammation and auto-immune diseases |
| 05/01/2013 | EP2586457A1 S 100 Family proteins and their uses |
| 05/01/2013 | EP2586456A1 Remodeling and glycopegylation of fibroblast growth factor (FGF) |
| 05/01/2013 | EP2586455A1 MicroRNA expressions abnormalities in pancreatic endocrine and acinar tumors |
| 05/01/2013 | EP2586454A1 MicroRNA expressions abnormalities in pancreatic endocrine and acinar tumors |
| 05/01/2013 | EP2586453A1 Tumor growth controlling method targeting galactosylceramide expression factor-1 |
| 05/01/2013 | EP2586440A2 Methods for preventing and treating microbial infections by modulating transcription factors |
| 05/01/2013 | EP2586439A1 Combination therapy with a compound acting as a platelet ADP receptor inhibitor |
| 05/01/2013 | EP2586305A1 Use of neuregulin for organ preservation |
| 05/01/2013 | EP2585592A2 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
| 05/01/2013 | EP2585486A1 Novel octapeptide compounds and therapeutic use thereof |
| 05/01/2013 | EP2585482A1 Glucagon analogues |
| 05/01/2013 | EP2585115A2 Cancer therapy |
| 05/01/2013 | EP2585114A2 Therapeutic conjugates of a dextrin polymer and an antimicrobial peptide |
| 05/01/2013 | EP2585109A2 Compositions and methods for preventing and treating organ injury and/or dysfunction |
| 05/01/2013 | EP2585105A2 Treatment of sanfilippo syndrome type b |
| 05/01/2013 | EP2585104A2 Methods and compositions for cns delivery of arylsulfatase a |
| 05/01/2013 | EP2585103A1 Method of treatment |
| 05/01/2013 | EP2585102A2 Amide-based insulin prodrugs |
| 05/01/2013 | EP2585101A1 Diabetes therapy |
| 05/01/2013 | EP2585100A2 Method for predicting a therapy response in subjects with multiple sclerosis |
| 05/01/2013 | EP2585099A2 Immunosuppression modulating compounds |
| 05/01/2013 | EP2585098A1 Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules and treatments using same |
| 05/01/2013 | EP2585097A2 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 05/01/2013 | EP2585096A2 Bifunctional conjugate compositions and associated methods |
| 05/01/2013 | EP2585095A1 Treatment of proliferative diseases |
| 05/01/2013 | EP2585094A1 Methods and pharmaceutical compositions for the treatment of respiratory tract infections |
| 05/01/2013 | EP2585093A2 Compositions and methods for treatment of thrombosis and prolonging survival of stored platelets |
| 05/01/2013 | EP2585092A1 Pharmaceutical composition containing goserelin for in-situ implant |